to 0·11)*−0·31 (−0·81 to 0·18)*..−0·35 (−0·59 to −0·10)*..−0·24 (−0·44 to −0·05)*−0·29 (−0·54 to −0·05)*−0·39 (−0·67 to −0·12)*−0·94 (−1·43 to −0·46)‡−1·02 (−1·19 to −0·85)‡−0·79 (−0·99 to −0·58)‡Teachers............................AtomoxetineClinicians....0·40 (−0·34 to 1·14)*0·01 (−0·41 to 0·42)*0·15 (−0·33 to 0·63)*..0·11 (−0·09 to 0·32)*..0·22 (0·05 to 0·39)*0·04 (−0·14 to 0·23)‡0·07 (−0·17 to 0·31)*−0·61 (−1·06 to −0·15)*−0·56 (−0·66 to −0·45)*−0·45 (−0·58 to −0·32)*Teachers....0·00 (−0·90 to 0·90)†......0·31 (−0·79 to 1·42)†..0·50 (−0·11 to 1·10)*..0·44 (− 0·19 to 1·07)*..−0·32 (−0·82 to 0·18)†..BupropionClinicians........−0·25 (−1·12 to 0·62)†..−0·28 (−1·04 to 0·47)†..−0·18 (−0·90 to 0·54)†0·04 (−0·38 to 0·45)*−0·33 (−1·10 to 0·43)†−0·62 (−1·20 to −0·03)*−0·96 (−1·69 to −0·22)‡−0·46 (−0·85 to −0·07)*Teachers............0·31 (−0·92 to 1·55)†..0·50 (−0·17 to 1·17)*..0·44 (−0·38 to 1·26)*..−0·32 (−1·07 to 0·43)†..ClonidineClinicians............−0·03 (−0·53 to 0·46)†..0·07 (−0·42 to 0·56)†..−0·08 (−0·59 to 0·43)†..−0·71 (−1·17 to −0·24)‡..GuanfacineClinicians................0·11 (−0·13 to 0·34)*..−0·05 (−0·32 to 0·23)*..−0·67 (−0·85 to −0·50)‡..Teachers................0·18 (−0·86 to 1·22)†..0·12 (−0·93 to 1·18)†..−0·63 (−1·62 to 0·35)†..MethylphenidateClinicians....................−0·15 (−0·41 to 0·10)*−0·65 (−1·11 to −0·19)*−0·78 (−0·93 to −0·62)‡−0·49 (−0·64 to −0·35)‡Teachers....................−0·06 (−0·53 to 0·42)†..−0·82 (−1·16 to −0·48)*..ModafinilClinicians........................−0·62 (−0·84 to −0·41)*0·16 (−0·28 to 0·59)*Teachers........................−0·76 (−1·15 to −0·37)†..Data are standardised mean difference (95% CI) between treatments. Results in bold are significant. Negative values favour the treatment in the row and positive values favour the treatment in the column. Drugs are reported in alphabetical
